Search research articles
Contact Us
Filters
Showing results (11-20 of 217) with videos related to
Page
of 22
Sort By:
Therapeutic Advances in Psychopharmacology
|
February 3, 2016
A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia
Steven G Potkin, Tatsuya Kimura, John Guarino
The International Journal of Neuropsychopharmacology
|
August 9, 2005
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
Roger M Lane, Steven G Potkin, Albert Enz
Clinical Schizophrenia & Related Psychoses
|
May 22, 2014
A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia
Steven G Potkin, Rimal Bera, Anna Eramo, et al.
Schizophrenia Research
|
November 5, 2002
Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide
Steven G Potkin, Ravi Anand, Larry Alphs, et al.
Journal of Clinical Psychopharmacology
|
January 2, 2013
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone
Steven G Potkin, Sheldon Preskorn, Marla Hochfeld, et al.
Schizophrenia Research
|
September 6, 2011
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
Steven G Potkin, Masaaki Ogasa, Josephine Cucchiaro, et al.
Biological Psychiatry
|
August 24, 2014
Imaging genetics approaches to identify mechanisms in severe mental illness
Steven G Potkin, Fabio Macciardi, Theo G M van Erp
Human Molecular Genetics
|
September 28, 2002
Pharmacogenomics in schizophrenia: the quest for individualized therapy
Vincenzo S Basile, Mario Masellis, Steven G Potkin, et al.
Biological Psychiatry
|
January 7, 2003
MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients
Margherita Molnar, Steven G Potkin, William E Bunney, et al.
The Journal of Clinical Psychiatry
|
November 11, 2010
Using new antipsychotics in your clinical practice
Steven G Potkin, Adrian Preda, Amir H Kalali, et al.
Page
of 22
Search research articles
Search
Showing results (11-20 of 217) with videos related to
Sort By:
Page
of 22
Therapeutic Advances in Psychopharmacology
|
February 3, 2016
A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia
Steven G Potkin, Tatsuya Kimura, John Guarino
The International Journal of Neuropsychopharmacology
|
August 9, 2005
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
Roger M Lane, Steven G Potkin, Albert Enz
Clinical Schizophrenia & Related Psychoses
|
May 22, 2014
A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia
Steven G Potkin, Rimal Bera, Anna Eramo, et al.
Schizophrenia Research
|
November 5, 2002
Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide
Steven G Potkin, Ravi Anand, Larry Alphs, et al.
Journal of Clinical Psychopharmacology
|
January 2, 2013
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone
Steven G Potkin, Sheldon Preskorn, Marla Hochfeld, et al.
Schizophrenia Research
|
September 6, 2011
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
Steven G Potkin, Masaaki Ogasa, Josephine Cucchiaro, et al.
Biological Psychiatry
|
August 24, 2014
Imaging genetics approaches to identify mechanisms in severe mental illness
Steven G Potkin, Fabio Macciardi, Theo G M van Erp
Human Molecular Genetics
|
September 28, 2002
Pharmacogenomics in schizophrenia: the quest for individualized therapy
Vincenzo S Basile, Mario Masellis, Steven G Potkin, et al.
Biological Psychiatry
|
January 7, 2003
MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients
Margherita Molnar, Steven G Potkin, William E Bunney, et al.
The Journal of Clinical Psychiatry
|
November 11, 2010
Using new antipsychotics in your clinical practice
Steven G Potkin, Adrian Preda, Amir H Kalali, et al.
Page
of 22